Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$8.58 - $17.65 $25,765 - $53,002
-3,003 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$10.17 - $18.96 $30,540 - $56,936
3,003 New
3,003 $55,000
Q3 2021

Nov 12, 2021

SELL
$11.67 - $18.07 $103,407 - $160,118
-8,861 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$17.92 - $25.86 $158,789 - $229,145
8,861 New
8,861 $162,000

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Hershey Trust CO Portfolio

Follow Hershey Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hershey Trust CO with notifications on news.